Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 1977-1982, April 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flammang, T. J.
Right arrow Articles by Kadlubar, F. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flammang, T. J.
Right arrow Articles by Kadlubar, F. F.

Arachidonic Acid-dependent Peroxidative Activation of Carcinogenic Arylamines by Extrahepatic Human Tissue Microsomes

Thomas J. Flammang1, Yasushi Yamazoe2, R. Wayne Benson, Dean W. Roberts, David W. Potter3, David Z. J. Chu, Nicholas P. Lang and Fred F. Kadlubar

Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, Arkansas 72079 [T. J. F., Y. Y., R. W. B., D. W. R., D. W. P., F. F. K.], and Department of Surgery, University of Arkansas for Medical Sciences and John L. McClellan Memorial Veterans Administration Medical Center, Little Rock, Arkansas 72205 [D.Z.J.C., N.P.L.]

Prostaglar din H synthase (PHS), an arachidonic acid-dependent peroxidase, has been implicated in the peroxidative activation of carcinogenic aromatic amines in extrahepatic carcinogen target tissues of experimental animals. We have examined the arachidonic acid-dependent activation of [3H]benzidine to DNA-bound products by microsomal prearations from 75 normal human tissues obtained during necessary surgical procedures. For several samples of urinary bladder epithelium, prostatic epithelium, colonic mucosa, and peripheral lung tissue, an arachidonic acid-dependent, microsomal-catalyzed activation of benzidine was observed; and the activity could be inhibited appreciably by indomethacin, a known inhibitor of PHS. Little or no arachidonic acid-dependent activity was detected in human placenta, breast, or liver microsomes or the majority of colon microsomes. Substrate specificity was also examined with purified ram PHS and with human bladder and with active colon preparations. Purified PHS catalyzed the activation of benzidine >> 2-naphthylamine, 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole > 4-aminobiphenyl > 2-amino-3-methylimidazo[4,5-f]quinoline > 3-amino-1-methyl-5H-pyrido[4,3-b] indole. In comparison, human bladder and colon microsomes catalyzed the activation of benzidine > 4-aminobiphenyl, 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole, 2-naphthylamine > 2-amino-3-methylimidazo[4,5-f]quinoline, 3-amino-1-methyl-5H-pyrido[4,3-b]indole. To confirm the occurrence of PHS antigen in human extrahepatic tissues, an avidin/biotin-amplified competitive enzyme-linked immunoabsorbent assay was developed with purified ram PHS and a commercially available monoclonal antibody known to cross-react with human platelet PHS. The avidin/biotin-amplified enzyme-linked immunosorbent assay, which detected ng quantities of ram PHS, clearly established the presence of the PHS protein in human bladder, prostate, and lung microsomes. In contrast, PES antigen was not detected in the liver or placental microsomes. The interindividual and tissue-dependent variability of PHS and its role in aromatic amine carcinogenesis are discussed.

1 To whom requests for reprints should be addressed, at HFT-110, NCTR, Jefferson, AR 72079.

2 FDA Visiting Scientist. Permanent address: Department of Pharmacology, School of Medicine, Keio University, Shinjuku-ku, Tokyo 160, Japan.

3 Present address: Department of Toxicology, Rohm & Haas Co., Spring House, PA 19477.

Received 7/14/88. Revised 12/20/88. Accepted 1/19/89.




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
Y. Feng, J. R. Neale, M. A. Doll, and D. W. Hein
Chemoprevention of Arylamine-Induced Colorectal Aberrant Crypts
Experimental Biology and Medicine, January 1, 2008; 233(1): 71 - 75.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Gago-Dominguez, D. A. Bell, M. A. Watson, J.-M. Yuan, J.E. Castelao, D. W. Hein, K. K. Chan, G. A. Coetzee, R. K. Ross, and M. C. Yu
Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2
Carcinogenesis, March 1, 2003; 24(3): 483 - 489.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. V. Zenser, V. M. Lakshmi, F. F. Hsu, and B. B. Davis
Methemoglobin Oxidation of N-Acetylbenzidine to Form a Sulfinamide
Drug Metab. Dispos., April 1, 2001; 29(4): 401 - 406.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
F. W. Wiese, P. A. Thompson, and F. F. Kadlubar
Carcinogen substrate specificity of human COX-1 and COX-2
Carcinogenesis, January 1, 2001; 22(1): 5 - 10.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Upadhyaya, P. M.J. Kenney, J. B. Hochalter, M. Wang, and S. S. Hecht
Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse
Carcinogenesis, August 1, 1999; 20(8): 1577 - 1582.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. V. Zenser, V. M. Lakshmi, F. F. Hsu, and B. B. Davis
Peroxygenase Metabolism of N-Acetylbenzidine by Prostaglandin H Synthase. FORMATION OF AN N-HYDROXYLAMINE
J. Biol. Chem., May 21, 1999; 274(21): 14850 - 14856.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Murata, K. Moriya, S. Inoue, and S. Kawanishi
Oxidative damage to cellular and isolated DNA by metabolites of a fungicide ortho-phenylphenol
Carcinogenesis, May 1, 1999; 20(5): 851 - 857.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. A.J. Schut and E. G. Snyderwine
DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis
Carcinogenesis, March 1, 1999; 20(3): 353 - 368.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T. V. Zenser, V. M. Lakshmi, and B. B. Davis
N-Glucuronidation of Benzidine and Its Metabolites. Role in Bladder Cancer
Drug Metab. Dispos., September 1, 1998; 26(9): 856 - 859.
[Abstract] [Full Text]


Home page
Drug Metab. Dispos.Home page
K. Datta, P. M. Sherblom, and A. P. Kulkarni
Co-oxidative Metabolism of 4-Aminobiphenyl by Lipoxygenase from Soybean and Human Term Placenta
Drug Metab. Dispos., February 1, 1997; 25(2): 196 - 105.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.